Cancer
Potential therapeutic implications of cancer stem cells in glioblastoma.
Cheng L, Bao S, Rich JN.
Biochem Pharmacol. 2010 Sep 1;80(5):654-65.
Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion
in tongue squamous cell carcinoma.
Jiang L, Liu X, Kolokythas A, Yu J, Wang A, Heidbreder CE, Shi F, Zhou X.
Int J Cancer. 2010 Aug 1;127(3):505-12.
Expression phenotype changes of EBV-transformed lymphoblastoid cell lines during long-term subculture and its clinical significance.
Lee JE, Nam HY, Shim SM, Bae GR, Han BG, Jeon JP.
Cell Prolif. 2010 Aug;43(4):378-84.
miR-138 might reverse multidrug resistance of leukemia cells.
Zhao X, Yang L, Hu J, Ruan J.
Leuk Res. 2010 Aug;34(8):1078-82.
Identification of suitable endogenous controls and differentially expressed microRNAs in canine fresh-frozen and FFPE lymphoma samples.
Mortarino M, Gioia G, Gelain ME, Albonico F, Roccabianca P, Ferri E, Comazzi S.
Leuk Res. 2010 Aug;34(8):1070-7.
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence.
Spahn M, Kneitz S, Scholz CJ, Stenger N, Rüdiger T, Ströbel P, Riedmiller H, Kneitz B.
Int J Cancer. 2010 Jul 15;127(2):394-403.
MicroRNA-34a is an important component of PRIMA-1-induced apoptotic network in human lung cancer cells.
Duan W, Gao L, Wu X, Wang L, Nana-Sinkam SP, Otterson GA, Villalona-Calero MA.
Int J Cancer. 2010 Jul 15;127(2):313-20.
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer.
Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X.
Int J Cancer. 2010 Jul 1;127(1):118-26.
Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA
methyltransferase 1.
Huang J, Wang Y, Guo Y, Sun S.
Hepatology. 2010 Jul;52(1):60-70.
Systemic microRNAs: novel biomarkers for colorectal and other cancers?
Heneghan HM, Miller N, Kerin MJ.
Gut. 2010 Jul;59(7):1002-4
The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis.
Hanoun N, Delpu Y, Suriawinata AA, Bournet B, Bureau C, Selves J, Tsongalis GJ, Dufresne M, Buscail L, Cordelier P, Torrisani J.
Clin Chem. 2010 Jul;56(7):1107-18.
The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice.
He XY, Chen JX, Zhang Z, Li CL, Peng QL, Peng HM.
J Cancer Res Clin Oncol. 2010 Jul;136(7):1023-8.
MicroRNAs as promising biomarkers for diagnosing human cancer.
Huang Y, Yang S, Zhang J, Tan L, Jiang F, Li N, Cheng J, Lu Y, Dai Y.
Cancer Invest. 2010 Jul;28(6):670-1.
Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
Sand M, Gambichler T, Skrygan M, Sand D, Scola N, Altmeyer P, Bechara FG.
Cancer Invest. 2010 Jul;28(6):649-53.
miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S, D'Andrea A, Ferla R, Surmacz E, Gulotta E, Amodeo V, Bazan V, Gebbia N, Russo A.
J Cell Physiol. 2010 Jul;224(1):242-9.
Cross-talk between miRNA and Notch signaling pathways in tumor development and progression.
Wang Z, Li Y, Kong D, Ahmad A, Banerjee S, Sarkar FH.
Cancer Lett. 2010 Jun 28;292(2):141-8.
A MicroRNA targeting dicer for metastasis control.
Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Daidone MG,
Bicciato S, Piccolo S.
Cell. 2010 Jun 25;141(7):1195-207.
A coding-independent function of gene and pseudogene mRNAs regulates tumour biology.
Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ, Pandolfi PP.
Nature. 2010 Jun 24;465(7301):1033-8.
TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through MIR199A2/214.
Yin G, Chen R, Alvero AB, Fu HH, Holmberg J, Glackin C, Rutherford T, Mor G.
Oncogene. 2010 Jun 17;29(24):3545-53.
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L.
Cancer Res. 2010 Jun 15;70(12):5184-93.
Downregulation of microRNA miR-520h by E1A contributes to anticancer activity.
Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, Cheng X, Hsiao M, Hung MC.
Cancer Res. 2010 Jun 15;70(12):5096-108.
Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP
levels.
Zhao J, Cao Y, Lei Z, Yang Z, Zhang B, Huang B.
Cancer Res. 2010 Jun 15;70(12):4850-8.
Myc-induced microRNAs integrate Myc-mediated cell proliferation and cell fate.
Kim JW, Mori S, Nevins JR.
Cancer Res. 2010 Jun 15;70(12):4820-8.
Concurrent suppression of integrin alpha5, radixin, and RhoA phenocopies the effects of miR-31 on metastasis.
Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA.
Cancer Res. 2010 Jun 15;70(12):5147-54.
Intronic miR-301 feedback regulates its host gene, ska2, in A549 cells by targeting MEOX2 to affect ERK/CREB pathways.
Cao G, Huang B, Liu Z, Zhang J, Xu H, Xia W, Li J, Li S, Chen L, Ding H, Zhao Q, Fan M, Shen B, Shao N.
Biochem Biophys Res Commun. 2010 Jun 11;396(4):978-82.
Negative regulation of tumor suppressor p53 by microRNA miR-504.
Hu W, Chan CS, Wu R, Zhang C, Sun Y, Song JS, Tang LH, Levine AJ, Feng Z.
Mol Cell. 2010 Jun 11;38(5):689-99.
De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures.
Ernst A, Campos B, Meier J, Devens F, Liesenberg F, Wolter M, Reifenberger G, Herold-Mende C, Lichter P, Radlwimmer B.
Oncogene. 2010 Jun 10;29(23):3411-22.
MicroRNA-206 expression levels correlate with clinical behaviour of rhabdomyosarcomas.
Missiaglia E, Shepherd CJ, Patel S, Thway K, Pierron G, Pritchard-Jones K, Renard M, Sciot R, Rao P, Oberlin O, Delattre O, Shipley J.
Br J Cancer. 2010 Jun 8;102(12):1769-77.
MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer.
Kong W, He L, Coppola M, Guo J, Esposito NN, Coppola D, Cheng JQ.
J Biol Chem. 2010 Jun 4;285(23):17869-79.
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of
gemcitabine activity.
Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, Leon LG, Pollina LE, Groen A, Falcone A, Danesi R, Campani D,
Verheul HM, Boggi U.
Cancer Res. 2010 Jun 1;70(11):4528-38.
Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors.
Doghman M, El Wakil A, Cardinaud B, Thomas E, Wang J, Zhao W, Peralta-Del Valle MH, Figueiredo BC, Zambetti GP, Lalli E.
Cancer Res. 2010 Jun 1;70(11):4666-75.
Downregulation of microRNA-200 in EBV-associated gastric carcinoma.
Shinozaki A, Sakatani T, Ushiku T, Hino R, Isogai M, Ishikawa S, Uozaki H, Takada K, Fukayama M.
Cancer Res. 2010 Jun 1;70(11):4719-27.
Estrogen receptor {beta}1 expression is regulated by miR-92 in breast cancer.
Al-Nakhle H, Burns PA, Cummings M, Hanby AM, Hughes TA, Satheesha S, Shaaban AM, Smith L, Speirs V.
Cancer Res. 2010 Jun 1;70(11):4778-84.
MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant
melanoma.
Satzger I, Mattern A, Kuettler U, Weinspach D, Voelker B, Kapp A, Gutzmer R.
Int J Cancer. 2010 Jun 1;126(11):2553-62.
E-cadherin transcriptional down-regulation by epigenetic and microRNA-200 family alterations is related to mesenchymal and
drug-resistant phenotypes in human breast cancer cells.
Tryndyak VP, Beland FA, Pogribny IP.
Int J Cancer. 2010 Jun 1;126(11):2575-83.
MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications.
Rachagani S, Kumar S, Batra SK.
Cancer Lett. 2010 Jun 1;292(1):8-16.
Repression of transposable-elements - a microRNA anti-cancer defense mechanism?
Shalgi R, Pilpel Y, Oren M.
Trends Genet. 2010 Jun;26(6):253-9.
The next thing in prognostic molecular markers: microRNA signatures of cancer.
Grady WM, Tewari M.
Gut. 2010 Jun;59(6):706-8.
Genomic profiling of Richter's syndrome: recurrent lesions and differences with de novo diffuse large B-cell lymphomas.
Scandurra M, Rossi D, Deambrogi C, Rancoita PM, Chigrinova E, Mian M, Cerri M, Rasi S, Sozzi E, Forconi F, Ponzoni M, Moreno SM,
Piris MA, Inghirami G, Zucca E, Gattei V, Rinaldi A, Kwee I, Gaidano G, Bertoni F.
Hematol Oncol. 2010 Jun;28(2):62-7.
Overexpression of dicer as a result of reduced let-7 MicroRNA levels contributes to increased cell proliferation of oral cancer cells.
Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ, Stewart CM, Cohen DM, Chan EK.
Genes Chromosomes Cancer. 2010 Jun;49(6):549-59.
MicroRNA-27a Indirectly Regulates Estrogen Receptor {alpha} Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells.
Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J, Safe S.
Endocrinology. 2010 Jun;151(6):2462-73.
Hypomethylation and genome instability in the germline of exposed parents and their progeny is associated with altered miRNA
expression.
Filkowski JN, Ilnytskyy Y, Tamminga J, Koturbash I, Golubov A, Bagnyukova T, Pogribny IP, Kovalchuk O.
Carcinogenesis. 2010 Jun;31(6):1110-5.
miR-22 functions as a micro-oncogene in transformed human bronchial epithelial cells induced by
anti-benzo[a]pyrene-7,8-diol-9,10-epoxide.
Liu L, Jiang Y, Zhang H, Greenlee AR, Yu R, Yang Q.
Toxicol In Vitro. 2010 Jun;24(4):1168-75.
Aurora kinase A induces miR-17-92 cluster through regulation of E2F1 transcription factor.
He S, Yang S, Deng G, Liu M, Zhu H, Zhang W, Yan S, Quan L, Bai J, Xu N.
Cell Mol Life Sci. 2010 Jun;67(12):2069-76.
MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.
Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS.
Carcinogenesis. 2010 Jun;31(6):1037-44.
Comprehensive miRNA profiling of surgically staged endometrial cancer.
Cohn DE, Fabbri M, Valeri N, Alder H, Ivanov I, Liu CG, Croce CM, Resnick KE.
Am J Obstet Gynecol. 2010 Jun;202(6):656.e1-8.
Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling.
Bueno MJ, Gómez de Cedrón M, Laresgoiti U, Fernández-Piqueras J, Zubiaga AM, Malumbres M.
Mol Cell Biol. 2010 Jun;30(12):2983-95.
MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma.
Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ; South Australian Oesophageal Research Group.
Br J Surg. 2010 Jun;97(6):853-61.
The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L, Han Y, Zhang H, Li M, Gong T, Sun L, Wu K, Zhao Q, Fan D.
Ann Surg. 2010 Jun;251(6):1056-63.
Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues.
Yi Z, Fu Y, Zhao S, Zhang X, Ma C.
J Cancer Res Clin Oncol. 2010 Jun;136(6):855-62.
Radiosensitive gene therapy through imRNA expression for silencing manganese superoxide dismutase.
Qu Y, Zhao S, Hong J, Tang S.
J Cancer Res Clin Oncol. 2010 Jun;136(6):953-9.
Differential expression of microRNA (miRNA) in chordoma reveals a role for miRNA-1 in Met expression.
Duan Z, Choy E, Nielsen GP, Rosenberg A, Iafrate J, Yang C, Schwab J, Mankin H, Xavier R, Hornicek FJ.
J Orthop Res. 2010 Jun;28(6):746-52.
MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3' untranslated region.
Tian S, Huang S, Wu S, Guo W, Li J, He X.
Biochem Biophys Res Commun. 2010 May 28;396(2):435-9.
Hsa-mir-182 suppresses lung tumorigenesis through down regulation of RGS17 expression in vitro.
Sun Y, Fang R, Li C, Li L, Li F, Ye X, Chen H.
Biochem Biophys Res Commun. 2010 May 28;396(2):501-7.
Foxo3a regulates apoptosis by negatively targeting miR-21.
Wang K, Li PF.
J Biol Chem. 2010 May 28;285(22):16958-66.
microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia.
Asslaber D, Piñón JD, Seyfried I, Desch P, Stöcher M, Tinhofer I, Egle A, Merkel O, Greil R.
Blood. 2010 May 27;115(21):4191-7.
MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer.
Di Leva G, Gasparini P, Piovan C, Ngankeu A, Garofalo M, Taccioli C, Iorio MV, Li M, Volinia S, Alder H, Nakamura T, Nuovo G, Liu Y,
Nephew KP, Croce CM.
J Natl Cancer Inst. 2010 May 19;102(10):706-21.
Signatures of microRNAs and selected microRNA target genes in human melanoma.
Philippidou D, Schmitt M, Moser D, Margue C, Nazarov PV, Muller A, Vallar L, Nashan D, Behrmann I, Kreis S.
Cancer Res. 2010 May 15;70(10):4163-73.
13q14 deletions in CLL involve cooperating tumor suppressors.
Palamarchuk A, Efanov A, Nazaryan N, Santanam U, Alder H, Rassenti L, Kipps T, Croce CM, Pekarsky Y.
Blood. 2010 May 13;115(19):3916-22.
MicroRNA and proliferation control in chronic lymphocytic leukemia: functional relationship between miR-221/222 cluster and p27.
Frenquelli M, Muzio M, Scielzo C, Fazi C, Scarfò L, Rossi C, Ferrari G, Ghia P, Caligaris-Cappio F.
Blood. 2010 May 13;115(19):3949-59.
IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer
and Leukemia Group B study.
Marcucci G, Maharry K, Wu YZ, Radmacher MD, Mrózek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, Metzeler KH,
Powell BL, Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Caligiuri MA, Larson RA, Bloomfield CD.
J Clin Oncol. 2010 May 10;28(14):2348-55.
Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through
microRNAs.
Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M.
Oncogene. 2010 May 6;29(18):2638-48.
microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.
Yu Z, Willmarth NE, Zhou J, Katiyar S, Wang M, Liu Y, McCue PA, Quong AA, Lisanti MP, Pestell RG.
Proc Natl Acad Sci U S A. 2010 May 4;107(18):8231-6.
hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, Ragoussis J, Harris AL.
Cancer. 2010 May 1;116(9):2148-58.
Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or
its analogue CDF.
Ali S, Ahmad A, Banerjee S, Padhye S, Dominiak K, Schaffert JM, Wang Z, Philip PA, Sarkar FH.
Cancer Res. 2010 May 1;70(9):3606-17.
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the
antiapoptotic protein PED.
Incoronato M, Garofalo M, Urso L, Romano G, Quintavalle C, Zanca C, Iaboni M, Nuovo G, Croce CM, Condorelli G.
Cancer Res. 2010 May 1;70(9):3638-46.
The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
Wong P, Iwasaki M, Somervaille TC, Ficara F, Carico C, Arnold C, Chen CZ, Cleary ML.
Cancer Res. 2010 May 1;70(9):3833-42.
Decreased expression of microRNA-199b increases protein levels of SET (protein phosphatase 2A inhibitor) in human choriocarcinoma.
Chao A, Tsai CL, Wei PC, Hsueh S, Chao AS, Wang CJ, Tsai CN, Lee YS, Wang TH, Lai CH.
Cancer Lett. 2010 May 1;291(1):99-107.
Targeted knockdown of Bcl2 in tumor cells using a synthetic TRAIL 3'-UTR microRNA.
Zhang J, Huang S, Zhang H, Wang H, Guo H, Qian G, Fan X, Lu J, Hoffman AR, Hu JF, Ge S.
Int J Cancer. 2010 May 1;126(9):2229-39.
Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer.
Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E, Busson P, Lo KW, Ng R, Waldron J, O'Sullivan B, Liu FF.
Int J Cancer. 2010 May 1;126(9):2036-48.
[MicroRNAs: novel biomarkers for human cancer]
Bartels CL, Tsongalis GJ.
Ann Biol Clin (Paris). 2010 May-Jun;68(3):263-72.
MicroRNAs in diagnosis and prognosis in cancer: what does the future hold?
Nana-Sinkam P, Croce CM.
Pharmacogenomics. 2010 May;11(5):667-9.
Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?
Germano I, Swiss V, Casaccia P.
Neuropharmacology. 2010 May;58(6):903-10.
Regulating the genome surveillance system: miRNAs and the p53 super family.
Bailey SG, Sanchez-Elsner T, Stephanou A, Cragg MS, Townsend PA.
Apoptosis. 2010 May;15(5):541-52.
S-MED: sarcoma microRNA expression database.
Sarver AL, Phalak R, Thayanithy V, Subramanian S.
Lab Invest. 2010 May;90(5):753-61.
CD5+CD23+ leukemic cell populations in TCL1 transgenic mice show significantly increased proliferation and Akt phosphorylation.
Efanov A, Zanesi N, Nazaryan N, Santanam U, Palamarchuk A, Croce CM, Pekarsky Y.
Leukemia. 2010 May;24(5):970-5.
Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G, Augugliaro L, Salemi D, Agueli C, La Rosa M, Dagnino L, Civiletto G, Messana F, Marfia A, Bica MG, Cascio L, Floridia
PM, Mineo AM, Russo M, Fabbiano F, Santoro A.
Am J Hematol. 2010 May;85(5):331-9.
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.
Carcinogenesis. 2010 May;31(5):766-76.
Complexity of miR-223 regulation by CEBPA in human AML.
Eyholzer M, Schmid S, Schardt JA, Haefliger S, Mueller BU, Pabst T.
Leuk Res. 2010 May;34(5):672-6.
Micro-RNA-15a and micro-RNA-16 expression and chromosome 13 deletions in multiple myeloma.
Corthals SL, Jongen-Lavrencic M, de Knegt Y, Peeters JK, Beverloo HB, Lokhorst HM, Sonneveld P.
Leuk Res. 2010 May;34(5):677-81.
Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis.
Hashimoto Y, Akiyama Y, Otsubo T, Shimada S, Yuasa Y.
Carcinogenesis. 2010 May;31(5):777-84.
MicroRNAs as gatekeepers of apoptosis.
Subramanian S, Steer CJ.
J Cell Physiol. 2010 May;223(2):289-98.
Modulation of microRNA expression by budesonide, phenethyl isothiocyanate and cigarette smoke in mouse liver and lung.
Izzotti A, Larghero P, Cartiglia C, Longobardi M, Pfeffer U, Steele VE, De Flora S.
Carcinogenesis. 2010 May;31(5):894-901.
MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with
gender and body mass index.
Langevin SM, Stone RA, Bunker CH, Grandis JR, Sobol RW, Taioli E.
Carcinogenesis. 2010 May;31(5):864-70.
miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock
protein 27 pathway.
Yang F, Yin Y, Wang F, Wang Y, Zhang L, Tang Y, Sun S.
Hepatology. 2010 May;51(5):1614-23.
Acute myeloid leukemia with t(9;11)(p21-22;q23): common properties of dysregulated ras pathway signaling and genomic progression
characterize de novo and therapy-related cases.
Chandra P, Luthra R, Zuo Z, Yao H, Ravandi F, Reddy N, Garcia-Manero G, Kantarjian H, Jones D.
Am J Clin Pathol. 2010 May;133(5):686-93.
MicroRNA-650 targets ING4 to promote gastric cancer tumorigenicity.
Zhang X, Zhu W, Zhang J, Huo S, Zhou L, Gu Z, Zhang M.
Biochem Biophys Res Commun. 2010 Apr 30;395(2):275-80.
High-risk myeloma is associated with global elevation of miRNAs and overexpression of EIF2C2/AGO2.
Zhou Y, Chen L, Barlogie B, Stephens O, Wu X, Williams DR, Cartron MA, van Rhee F, Nair B, Waheed S, Pineda-Roman M, Alsayed Y,
Anaissie E, Shaughnessy JD Jr.
Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7904-9.
Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine.
Blum W, Garzon R, Klisovic RB, Schwind S, Walker A, Geyer S, Liu S, Havelange V, Becker H, Schaaf L, Mickle J, Devine H, Kefauver C,
Devine SM, Chan KK, Heerema NA, Bloomfield CD, Grever MR, Byrd JC, Villalona-Calero M, Croce CM, Marcucci G.
Proc Natl Acad Sci U S A. 2010 Apr 20;107(16):7473-8.
Epigenetic repression of microRNA-129-2 leads to overexpression of SOX4 in gastric cancer.
Shen R, Pan S, Qi S, Lin X, Cheng S.
Biochem Biophys Res Commun. 2010 Apr 16;394(4):1047-52.
Update in lung cancer and mesothelioma 2009.
Sculier JP, Berghmans T, Meert AP.
Am J Respir Crit Care Med. 2010 Apr 15;181(8):773-81.
Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1).
Borgdorff V, Lleonart ME, Bishop CL, Fessart D, Bergin AH, Overhoff MG, Beach DH.
Oncogene. 2010 Apr 15;29(15):2262-71.
Targeting of mRNAs by multiple miRNAs: the next step.
Peter ME.
Oncogene. 2010 Apr 15;29(15):2161-4.
Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3' untranslated region.
Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X.
Oncogene. 2010 Apr 15;29(15):2302-8.
MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene.
Jiang S, Zhang HW, Lu MH, He XH, Li Y, Gu H, Liu MF, Wang ED.
Cancer Res. 2010 Apr 15;70(8):3119-27.
Oncogenic role of miR-483-3p at the IGF2/483 locus.
Veronese A, Lupini L, Consiglio J, Visone R, Ferracin M, Fornari F, Zanesi N, Alder H, D'Elia G, Gramantieri L, Bolondi L, Lanza G,
Querzoli P, Angioni A, Croce CM, Negrini M.
Cancer Res. 2010 Apr 15;70(8):3140-9.
Modulation of mismatch repair and genomic stability by miR-155.
Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, Adair B, Vannini I, Fanini F, Bottoni A, Costinean S, Sandhu SK, Nuovo
GJ, Alder H, Gafa R, Calore F, Ferracin M, Lanza G, Volinia S, Negrini M, McIlhatton MA, Amadori D, Fishel R, Croce CM.
Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6982-7.
Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer.
White NM, Chow TF, Mejia-Guerrero S, Diamandis M, Rofael Y, Faragalla H, Mankaruous M, Gabril M, Girgis A, Yousef GM.
Br J Cancer. 2010 Apr 13;102(8):1244-53.
Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia.
Liu S, Wu LC, Pang J, Santhanam R, Schwind S, Wu YZ, Hickey CJ, Yu J, Becker H, Maharry K, Radmacher MD, Li C, Whitman SP,
Mishra A, Stauffer N, Eiring AM, Briesewitz R, Baiocchi RA, Chan KK, Paschka P, Caligiuri MA, Byrd JC, Croce CM, Bloomfield CD,
Perrotti D, Garzon R, Marcucci G.
Cancer Cell. 2010 Apr 13;17(4):333-47.
Differentiation-associated miR-22 represses Max expression and inhibits cell cycle progression.
Ting Y, Medina DJ, Strair RK, Schaar DG.
Biochem Biophys Res Commun. 2010 Apr 9;394(3):606-11.
MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.
Liu AM, Poon RT, Luk JM.
Biochem Biophys Res Commun. 2010 Apr 9;394(3):623-7.
P53-induced microRNA-107 inhibits HIF-1 and tumor angiogenesis.
Yamakuchi M, Lotterman CD, Bao C, Hruban RH, Karim B, Mendell JT, Huso D, Lowenstein CJ.
Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9.
Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.
Lee Y, Yang X, Huang Y, Fan H, Zhang Q, Wu Y, Li J, Hasina R, Cheng C, Lingen MW, Gerstein MB, Weichselbaum RR, Xing HR, Lussier
YA.
PLoS Comput Biol. 2010 Apr 1;6(4):e1000730.
microRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell
lymphoma.
Zhao JJ, Lin J, Lwin T, Yang H, Guo J, Kong W, Dessureault S, Moscinski LC, Rezania D, Dalton WS, Sotomayor E, Tao J, Cheng JQ.
Blood. 2010 Apr 1;115(13):2630-9.
The dicey role of Dicer: implications for RNAi therapy.
Merritt WM, Bar-Eli M, Sood AK.
Cancer Res. 2010 Apr 1;70(7):2571-4.
MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis.
Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, Tan CT, Lin MT, Kuo ML.
Cancer Res. 2010 Apr 1;70(7):2675-85.
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.
Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, Tanaka Y, Dahiya R.
Cancer Res. 2010 Apr 1;70(7):2809-18.
Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets.
Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ,
Coleman N; Children's Cancer and Leukaemia Group.
Cancer Res. 2010 Apr 1;70(7):2911-23.
MicroRNA145 targets BNIP3 and suppresses prostate cancer progression.
Chen X, Gong J, Zeng H, Chen N, Huang R, Huang Y, Nie L, Xu M, Xia J, Zhao F, Meng W, Zhou Q.
Cancer Res. 2010 Apr 1;70(7):2728-38.
Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung
cancer.
Hu Z, Chen X, Zhao Y, Tian T, Jin G, Shu Y, Chen Y, Xu L, Zen K, Zhang C, Shen H.
J Clin Oncol. 2010 Apr 1;28(10):1721-6.
MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site.
Choi HJ, Lee H, Kim H, Kwon JE, Kang HJ, You KT, Rhee H, Noh SH, Paik YK, Hyung WJ, Kim H.
Int J Cancer. 2010 Apr 1;126(7):1640-50.
Dysregulation of kallikrein-related peptidases in renal cell carcinoma: potential targets of miRNAs.
White NM, Bui A, Mejia-Guerrero S, Chao J, Soosaipillai A, Youssef Y, Mankaruos M, Honey RJ, Stewart R, Pace KT, Sugar L, Diamandis
EP, Doré J, Yousef GM.
Biol Chem. 2010 Apr;391(4):411-23.
MiR-320 and miR-494 affect cell cycles of primary murine bronchial epithelial cells exposed to benzo[a]pyrene.
Duan H, Jiang Y, Zhang H, Wu Y.
Toxicol In Vitro. 2010 Apr;24(3):928-35.
Monoallelic but not biallelic loss of Dicer1 promotes tumorigenesis in vivo.
Lambertz I, Nittner D, Mestdagh P, Denecker G, Vandesompele J, Dyer MA, Marine JC.
Cell Death Differ. 2010 Apr;17(4):633-41.
MicroRNA-181a sensitizes human malignant glioma U87MG cells to radiation by targeting Bcl-2.
Chen G, Zhu W, Shi D, Lv L, Zhang C, Liu P, Hu W.
Oncol Rep. 2010 Apr;23(4):997-1003.
The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma.
Qu Y, Zhang H, Zhao S, Hong J, Tang C.
Oncol Rep. 2010 Apr;23(4):1005-11.
Non-coding RNAs: identification of cancer-associated microRNAs by gene profiling.
Ferdin J, Kunej T, Calin GA.
Technol Cancer Res Treat. 2010 Apr;9(2):123-38.
Innate immune signaling in the myelodysplastic syndromes.
Starczynowski DT, Karsan A.
Hematol Oncol Clin North Am. 2010 Apr;24(2):343-59.
Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue?
Young MR, Santhanam AN, Yoshikawa N, Colburn NH.
Mol Interv. 2010 Apr;10(2):76-9.
Micromarkers: miRNAs in cancer diagnosis and prognosis.
Ferracin M, Veronese A, Negrini M.
Expert Rev Mol Diagn. 2010 Apr;10(3):297-308.
[Transient transformation as a permanent oncogenic loop]
Coqueret O, Barré B.
Med Sci (Paris). 2010 Apr;26(4):339-41.
MicroRNAs in cancer - from research to therapy.
Cho WC.
Biochim Biophys Acta. 2010 Apr;1805(2):209-17.
Helpers of the cellular gatekeeper-miRNAs dance in P53 network.
Shi M, Liu D, Shen B, Guo N.
Biochim Biophys Acta. 2010 Apr;1805(2):218-25.
Hsa-miR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met.
Cai KM, Bao XL, Kong XH, Jinag W, Mao MR, Chu JS, Huang YJ, Zhao XJ.
Int J Mol Med. 2010 Apr;25(4):565-71.
miR-221/222 promote malignant progression of glioma through activation of the Akt pathway.
Zhang J, Han L, Ge Y, Zhou X, Zhang A, Zhang C, Zhong Y, You Y, Pu P, Kang C.
Int J Oncol. 2010 Apr;36(4):913-20.
IGF activation in a molecular subclass of hepatocellular carcinoma and pre-clinical efficacy of IGF-1R blockage.
Tovar V, Alsinet C, Villanueva A, Hoshida Y, Chiang DY, Solé M, Thung S, Moyano S, Toffanin S, Mínguez B, Cabellos L, Peix J, Schwartz
M, Mazzaferro V, Bruix J, Llovet JM.
J Hepatol. 2010 Apr;52(4):550-9.
Antagonizing metastasis.
De Palma M, Naldini L.
Nat Biotechnol. 2010 Apr;28(4):331-2.
Cellular senescence in usual type uterine leiomyoma.
Laser J, Lee P, Wei JJ.
Fertil Steril. 2010 Apr;93(6):2020-6.
Identification of a microRNA panel for clear-cell kidney cancer.
Juan D, Alexe G, Antes T, Liu H, Madabhushi A, Delisi C, Ganesan S, Bhanot G, Liou LS.
Urology. 2010 Apr;75(4):835-41.
microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network.
Zhang L, Deng T, Li X, Liu H, Zhou H, Ma J, Wu M, Zhou M, Shen S, Li X, Niu Z, Zhang W, Shi L, Xiang B, Lu J, Wang L, Li D, Tang H, Li G.
Carcinogenesis. 2010 Apr;31(4):559-66.
MicroRNA-21 is induced early in pancreatic ductal adenocarcinoma precursor lesions.
du Rieu MC, Torrisani J, Selves J, Al Saati T, Souque A, Dufresne M, Tsongalis GJ, Suriawinata AA, Carrère N, Buscail L, Cordelier P.
Clin Chem. 2010 Apr;56(4):603-12.
Epigenetic inactivation of the miR-34a in hematological malignancies.
Chim CS, Wong KY, Qi Y, Loong F, Lam WL, Wong LG, Jin DY, Costello JF, Liang R.
Carcinogenesis. 2010 Apr;31(4):745-50.
A potential microRNA signature for tumorigenic conazoles in mouse liver.
Ross JA, Blackman CF, Thai SF, Li Z, Kohan M, Jones CP, Chen T.
Mol Carcinog. 2010 Apr;49(4):320-3.
An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell
lines and clinical samples.
Xiong J, Yu D, Wei N, Fu H, Cai T, Huang Y, Wu C, Zheng X, Du Q, Lin D, Liang Z.
FEBS J. 2010 Apr;277(7):1684-94.
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia.
Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, de Keersmaecker K, McJunkin K, Zuber J, James T, Khan AA, Leslie CS, Parker JS,
Paddison PJ, Tam W, Ferrando A, Wendel HG.
Nat Cell Biol. 2010 Apr;12(4):372-9.
MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors.
Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, Luo Y, Demidenko E, Korc M, Shi W, Preis M, Dragnev KH, Li H, Direnzo J, Bak
M, Freemantle SJ, Kauppinen S, Dmitrovsky E.
J Clin Invest. 2010 Apr;120(4):1298-309.
Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA.
Ding J, Huang S, Wu S, Zhao Y, Liang L, Yan M, Ge C, Yao J, Chen T, Wan D, Wang H, Gu J, Yao M, Li J, Tu H, He X.
Nat Cell Biol. 2010 Apr;12(4):390-9.
Correlation of overexpression of HMGA1 and HMGA2 with poor tumor differentiation, invasion, and proliferation associated with let-7
down-regulation in retinoblastomas.
Mu G, Liu H, Zhou F, Xu X, Jiang H, Wang Y, Qu Y.
Hum Pathol. 2010 Apr;41(4):493-502.
Identification of microRNAs controlling human ovarian cell proliferation and apoptosis.
Sirotkin AV, Lauková M, Ovcharenko D, Brenaut P, Mlyncek M.
J Cell Physiol. 2010 Apr;223(1):49-56.
MicroRNAs reduce tumor growth and contribute to enhance cytotoxicity induced by gefitinib in non-small cell lung cancer.
Zhong M, Ma X, Sun C, Chen L.
Chem Biol Interact. 2010 Mar 30;184(3):431-8.
Circulating microRNAs in plasma of patients with gastric cancers.
Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji
E.
Br J Cancer. 2010 Mar 30;102(7):1174-9.
TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3.
Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, Ghoshal K.
Oncogene. 2010 Mar 25;29(12):1787-97.
Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner.
Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY.
Oncogene. 2010 Mar 25;29(12):1763-72.
p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication.
Cannell IG, Kong YW, Johnston SJ, Chen ML, Collins HM, Dobbyn HC, Elia A, Kress TR, Dickens M, Clemens MJ, Heery DM, Gaestel M,
Eilers M, Willis AE, Bushell M.
Proc Natl Acad Sci U S A. 2010 Mar 23;107(12):5375-80.
Microrna profiling analysis of differences between the melanoma of young adults and older adults.
Jukic DM, Rao UN, Kelly L, Skaf JS, Drogowski LM, Kirkwood JM, Panelli MC.
J Transl Med. 2010 Mar 19;8:27.
Micro-RNAs and copy number changes: new levels of gene regulation in acute myeloid leukemia.
Larson RA.
Chem Biol Interact. 2010 Mar 19;184(1-2):21-5.
MicroRNA-induced silencing of glioma progression.
Wong JW.
J Neurosci. 2010 Mar 17;30(11):3868-9.
Scientists probe microRNAs' role in cancer.
Hampton T.
JAMA. 2010 Mar 17;303(11):1025.
MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y, Li Z, He C, Wang D, Yuan X, Chen J, Jin J.
Blood Cells Mol Dis. 2010 Mar 15;44(3):191-7.
Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis.
Sudbery I, Enright AJ, Fraser AG, Dunham I.
BMC Genomics. 2010 Mar 15;11:175.
microRNA-29a induces aberrant self-renewal capacity in hematopoietic progenitors, biased myeloid development, and acute myeloid
leukemia.
Han YC, Park CY, Bhagat G, Zhang J, Wang Y, Fan JB, Liu M, Zou Y, Weissman IL, Gu H.
J Exp Med. 2010 Mar 15;207(3):475-89.
MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M.
Cancer Res. 2010 Mar 15;70(6):2339-49.
Environmental factors and genetic susceptibility promote urinary bladder cancer.
Volanis D, Kadiyska T, Galanis A, Delakas D, Logotheti S, Zoumpourlis V.
Toxicol Lett. 2010 Mar 15;193(2):131-7.
B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
Leucci E, Onnis A, Cocco M, De Falco G, Imperatore F, Giuseppina A, Costanzo V, Cerino G, Mannucci S, Cantisani R, Nyagol J,
Mwanda W, Iriso R, Owang M, Schurfeld K, Bellan C, Lazzi S, Leoncini L.
Int J Cancer. 2010 Mar 15;126(6):1316-26.
miRNA control of tumor cell invasion and metastasis.
Baranwal S, Alahari SK.
Int J Cancer. 2010 Mar 15;126(6):1283-90.
Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated
protein 1.
Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H.
Biochem Pharmacol. 2010 Mar 15;79(6):817-24.
MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines.
Tian Y, Luo A, Cai Y, Su Q, Ding F, Chen H, Liu Z.
J Biol Chem. 2010 Mar 12;285(11):7986-94.
MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.
Godlewski J, Nowicki MO, Bronisz A, Nuovo G, Palatini J, De Lay M, Van Brocklyn J, Ostrowski MC, Chiocca EA, Lawler SE.
Mol Cell. 2010 Mar 12;37(5):620-32.
MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor.
Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D.
PLoS Genet. 2010 Mar 12;6(3):e1000879.
MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
Mestdagh P, Fredlund E, Pattyn F, Schulte JH, Muth D, Vermeulen J, Kumps C, Schlierf S, De Preter K, Van Roy N, Noguera R, Laureys
G, Schramm A, Eggert A, Westermann F, Speleman F, Vandesompele J.
Oncogene. 2010 Mar 4;29(9):1394-404.
Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia.
Pulikkan JA, Dengler V, Peramangalam PS, Peer Zada AA, Müller-Tidow C, Bohlander SK, Tenen DG, Behre G.
Blood. 2010 Mar 4;115(9):1768-78.
miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer.
Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M.
Br J Cancer. 2010 Mar 2;102(5):883-91.
Melanoma MicroRNA signature predicts post-recurrence survival.
Segura MF, Belitskaya-Lévy I, Rose AE, Zakrzewski J, Gaziel A, Hanniford D, Darvishian F, Berman RS, Shapiro RL, Pavlick AC, Osman
I, Hernando E.
Clin Cancer Res. 2010 Mar 1;16(5):1577-86.
miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, Criollo A, Servant N, Paccard C, Hupé P, Robert T, Ripoche H, Lazar V, Harel-Bellan
A, Dessen P, Barillot E, Kroemer G.
Cancer Res. 2010 Mar 1;70(5):1793-803.
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.
Pass HI, Goparaju C, Ivanov S, Donington J, Carbone M, Hoshen M, Cohen D, Chajut A, Rosenwald S, Dan H, Benjamin S, Aharonov R.
Cancer Res. 2010 Mar 1;70(5):1916-24.
Regulation of the microRNA processor DGCR8 by the tumor suppressor ING1.
Gómez-Cabello D, Callejas S, Benguría A, Moreno A, Alonso J, Palmero I.
Cancer Res. 2010 Mar 1;70(5):1866-74.
Molecular profiling uncovers a p53-associated role for microRNA-31 in inhibiting the proliferation of serous ovarian carcinomas and other
cancers.
Creighton CJ, Fountain MD, Yu Z, Nagaraja AK, Zhu H, Khan M, Olokpa E, Zariff A, Gunaratne PH, Matzuk MM, Anderson ML.
Cancer Res. 2010 Mar 1;70(5):1906-15.
Metalloproteinases and their regulators in colorectal cancer.
van der Jagt MF, Wobbes T, Strobbe LJ, Sweep FC, Span PN.
J Surg Oncol. 2010 Mar 1;101(3):259-69.
miR-125b-2 is a potential oncomiR on human chromosome 21 in megakaryoblastic leukemia.
Klusmann JH, Li Z, Böhmer K, Maroz A, Koch ML, Emmrich S, Godinho FJ, Orkin SH, Reinhardt D.
Genes Dev. 2010 Mar 1;24(5):478-90.
Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
Int J Cancer. 2010 Mar 1;126(5):1166-76.
The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer.
Ribas J, Lupold SE.
Cell Cycle. 2010 Mar;9(5):923-9.
Micro-orchestrating differentiation in cancer.
Taulli R, Bersani F, Ponzetto C.
Cell Cycle. 2010 Mar;9(5):918-22.
Up-regulation of microRNA in bladder tumor tissue is not common.
Wang G, Zhang H, He H, Tong W, Wang B, Liao G, Chen Z, Du C.
Int Urol Nephrol. 2010 Mar;42(1):95-102.
Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
Gandellini P, Folini M, Zaffaroni N.
Discov Med. 2010 Mar;9(46):212-8.
MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression.
Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L, Lloyd RV.
Mod Pathol. 2010 Mar;23(3):367-75.
microRNA, cell cycle, and human breast cancer.
Yu Z, Baserga R, Chen L, Wang C, Lisanti MP, Pestell RG.
Am J Pathol. 2010 Mar;176(3):1058-64.
Pdcd4, a colon cancer prognostic that is regulated by a microRNA.
Allgayer H.
Crit Rev Oncol Hematol. 2010 Mar;73(3):185-91.
microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells.
Pan Q, Luo X, Chegini N.
Mol Hum Reprod. 2010 Mar;16(3):215-27.
Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
Tsang WP, Ng EK, Ng SS, Jin H, Yu J, Sung JJ, Kwok TT.
Carcinogenesis. 2010 Mar;31(3):350-8.
Upregulation of mir-221 and mir-222 in atypical teratoid/rhabdoid tumors: potential therapeutic targets.
Sredni ST, Bonaldo Mde F, Costa FF, Huang CC, Hamm CA, Rajaram V, Tomita T, Goldman S, Bischof JM, Soares MB.
Childs Nerv Syst. 2010 Mar;26(3):279-83.
Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinoma.
Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM.
Hepatology. 2010 Mar;51(3):836-45.
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma.
Yao J, Liang L, Huang S, Ding J, Tan N, Zhao Y, Yan M, Ge C, Zhang Z, Chen T, Wan D, Yao M, Li J, Gu J, He X.
Hepatology. 2010 Mar;51(3):846-56.
Lung cancer: from single-gene methylation to methylome profiling.
Heller G, Zielinski CC, Zöchbauer-Müller S.
Cancer Metastasis Rev. 2010 Mar;29(1):95-107.
Breast cancer epigenetics: from DNA methylation to microRNAs.
Veeck J, Esteller M.
J Mammary Gland Biol Neoplasia. 2010 Mar;15(1):5-17.
microRNAs and lung cancer: tumors and 22-mers.
Du L, Pertsemlidis A.
Cancer Metastasis Rev. 2010 Mar;29(1):109-22.
SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control.
Sun S, Zhang Z, Sinha R, Karni R, Krainer AR.
Nat Struct Mol Biol. 2010 Mar;17(3):306-12.
MicroRNA-dependent regulation of DNA methyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant
cholangiocytes.
Braconi C, Huang N, Patel T.
Hepatology. 2010 Mar;51(3):881-90.
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S, Westermann F,
Speleman F, Vandesompele J, Weinberg RA.
Nat Cell Biol. 2010 Mar;12(3):247-56.
Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces
transcriptional plasticity.
Coolen MW, Stirzaker C, Song JZ, Statham AL, Kassir Z, Moreno CS, Young AN, Varma V, Speed TP, Cowley M, Lacaze P, Kaplan W,
Robinson MD, Clark SJ.
Nat Cell Biol. 2010 Mar;12(3):235-46.
Myc-modulated miR-9 makes more metastases.
Khew-Goodall Y, Goodall GJ.
Nat Cell Biol. 2010 Mar;12(3):209-11.
[Application of microRNAs to Cancer Therapy]
Iguchi H, Ochiya T.
Gan To Kagaku Ryoho. 2010 Mar;37(3):389-95.
Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling.
Gutiérrez NC, Sarasquete ME, Misiewicz-Krzeminska I, Delgado M, De Las Rivas J, Ticona FV, Fermiñán E, Martín-Jiménez P, Chillón C,
Risueño A, Hernández JM, García-Sanz R, González M, San Miguel JF.
Leukemia. 2010 Mar;24(3):629-37.
Nuclear factor-{kappa}B contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a.
Pacifico F, Crescenzi E, Mellone S, Iannetti A, Porrino N, Liguoro D, Moscato F, Grieco M, Formisano S, Leonardi A.
J Clin Endocrinol Metab. 2010 Mar;95(3):1421-30.
Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ.
Ann Surg. 2010 Mar;251(3):499-505.
Significant inverse correlation of microRNA-150/MYB and microRNA-222/p27 in myelodysplastic syndrome.
Hussein K, Theophile K, Büsche G, Schlegelberger B, Göhring G, Kreipe H, Bock O.
Leuk Res. 2010 Mar;34(3):328-34.
MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications.
Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G.
Am J Respir Cell Mol Biol. 2010 Mar;42(3):312-9.
microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance.
Wieser R, Scheideler M, Hackl H, Engelmann M, Schneckenleithner C, Hiden K, Papak C, Trajanoski Z, Sill H, Fonatsch C.
Genes Chromosomes Cancer. 2010 Mar;49(3):193-203.
Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and
chromosome copy number variations.
Wang HW, Wu YH, Hsieh JY, Liang ML, Chao ME, Liu DJ, Hsu MT, Wong TT.
BMC Genomics. 2010 Feb 24;11:132.
Aberrant overexpression and function of the miR-17-92 cluster in MLL-rearranged acute leukemia.
Mi S, Li Z, Chen P, He C, Cao D, Elkahloun A, Lu J, Pelloso LA, Wunderlich M, Huang H, Luo RT, Sun M, He M, Neilly MB, Zeleznik-Le NJ,
Thirman MJ, Mulloy JC, Liu PP, Rowley JD, Chen J.
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3710-5.
miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy.
Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald HA, Reinhart TA, Martinson J, Lotze MT, Marincola FM, Wang E, Fujita M, Okada H.
J Transl Med. 2010 Feb 18;8:17.
Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue.
Corbetta S, Vaira V, Guarnieri V, Scillitani A, Eller-Vainicher C, Ferrero S, Vicentini L, Chiodini I, Bisceglia M, Beck-Peccoz P, Bosari S,
Spada A.
Endocr Relat Cancer. 2010 Feb 18;17(1):135-46.
STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.
Li G, Miskimen KL, Wang Z, Xie XY, Brenzovich J, Ryan JJ, Tse W, Moriggl R, Bunting KD.
Blood. 2010 Feb 18;115(7):1416-24.
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature
present in Ta bladder tumors.
Ostenfeld MS, Bramsen JB, Lamy P, Villadsen SB, Fristrup N, Sørensen KD, Ulhøi B, Borre M, Kjems J, Dyrskjøt L, Orntoft TF.
Oncogene. 2010 Feb 18;29(7):1073-84.
The microRNA network and tumor metastasis.
Zhang H, Li Y, Lai M.
Oncogene. 2010 Feb 18;29(7):937-48.
Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis.
Rai D, Kim SW, McKeller MR, Dahia PL, Aguiar RC.
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3111-6.
Frequent downregulation of miR-34 family in human ovarian cancers.
Corney DC, Hwang CI, Matoso A, Vogt M, Flesken-Nikitin A, Godwin AK, Kamat AA, Sood AK, Ellenson LH, Hermeking H, Nikitin AY.
Clin Cancer Res. 2010 Feb 15;16(4):1119-28.
Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas.
Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings
B, Liu FF.
Clin Cancer Res. 2010 Feb 15;16(4):1129-39.
miR-146a suppresses invasion of pancreatic cancer cells.
Li Y, Vandenboom TG 2nd, Wang Z, Kong D, Ali S, Philip PA, Sarkar FH.
Cancer Res. 2010 Feb 15;70(4):1486-95.
A microRNA expression signature for cervical cancer prognosis.
Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW, Wang X.
Cancer Res. 2010 Feb 15;70(4):1441-8.
miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma.
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY, Wu KJ, Chiou SH, Lin SC, Chang KW.
Cancer Res. 2010 Feb 15;70(4):1635-44.
Downregulations of B-cell lymphoma 2 and myeloid cell leukemia sequence 1 by microRNA 153 induce apoptosis in a glioblastoma cell
line DBTRG-05MG.
Xu J, Liao X, Wong C.
Int J Cancer. 2010 Feb 15;126(4):1029-35.
An evidence for adhesion-mediated acquisition of acute myeloid leukemic stem cell-like immaturities.
Funayama K, Shimane M, Nomura H, Asano S.
Biochem Biophys Res Commun. 2010 Feb 12;392(3):271-6.
MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.
Wu Q, Jin H, Yang Z, Luo G, Lu Y, Li K, Ren G, Su T, Pan Y, Feng B, Xue Z, Wang X, Fan D.
Biochem Biophys Res Commun. 2010 Feb 12;392(3):340-5.
MicroRNAs, development of Barrett's esophagus, and progression to esophageal adenocarcinoma.
Smith CM, Watson DI, Michael MZ, Hussey DJ.
World J Gastroenterol. 2010 Feb 7;16(5):531-7.
MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation.
Shi L, Zhang J, Pan T, Zhou J, Gong W, Liu N, Fu Z, You Y.
Brain Res. 2010 Feb 2;1312:120-6.
Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.
Kim H, Huang W, Jiang X, Pennicooke B, Park PJ, Johnson MD.
Proc Natl Acad Sci U S A. 2010 Feb 2;107(5):2183-8.
MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling.
Wong QW, Ching AK, Chan AW, Choy KW, To KF, Lai PB, Wong N.
Clin Cancer Res. 2010 Feb 1;16(3):867-75.
Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes.
Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G, Suzuki T, Croce CM, Patel T.
Clin Cancer Res. 2010 Feb 1;16(3):957-66.
Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.
Dang CV.
Cancer Res. 2010 Feb 1;70(3):859-62.
Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and
associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.
Becker H, Marcucci G, Maharry K, Radmacher MD, Mrózek K, Margeson D, Whitman SP, Wu YZ, Schwind S, Paschka P, Powell BL,
Carter TH, Kolitz JE, Wetzler M, Carroll AJ, Baer MR, Caligiuri MA, Larson RA, Bloomfield CD.
J Clin Oncol. 2010 Feb 1;28(4):596-604.
MicroRNAs and cancer: a meeting summary of the eponymous Keystone Conference.
Godshalk SE, Melnik-Martinez KV, Pasquinelli AE, Slack FJ.
Epigenetics. 2010 Feb;5(2):164-8.
Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis.
Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ.
J Dig Dis. 2010 Feb;11(1):50-4.
Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma.
Imbeaud S, Ladeiro Y, Zucman-Rossi J.
Semin Liver Dis. 2010 Feb;30(1):75-86.
Role of thrombin as a tumor growth factor.
Green D, Karpatkin S.
Cell Cycle. 2010 Feb;9(4):656-61.
Glioblastoma genetics: in rapid flux.
Purow BW, Schiff D.
Discov Med. 2010 Feb;9(45):125-31.
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
Tsang WP, Kwok TT.
J Nutr Biochem. 2010 Feb;21(2):140-6.
Pleiotropic anti-myeloma activity of ITF2357: inhibition of interleukin-6 receptor signaling and repression of miR-19a and miR-19b.
Todoerti K, Barbui V, Pedrini O, Lionetti M, Fossati G, Mascagni P, Rambaldi A, Neri A, Introna M, Lombardi L, Golay J.
Haematologica. 2010 Feb;95(2):260-9.
Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.
Khan AP, Poisson LM, Bhat VB, Fermin D, Zhao R, Kalyana-Sundaram S, Michailidis G, Nesvizhskii AI, Omenn GS, Chinnaiyan AM,
Sreekumar A.
Mol Cell Proteomics. 2010 Feb;9(2):298-312.
Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis.
Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S, Alder H, Liu CG, Oue N, Yasui W, Yoshida K, Sasaki H, Nomura S, Seto Y,
Kaminishi M, Calin GA, Croce CM.
Lancet Oncol. 2010 Feb;11(2):136-46.
Using microRNAs to understand cancer biology.
Weidhaas J.
Lancet Oncol. 2010 Feb;11(2):106-7.
A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer.
Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG, Olokpa E, Itamochi H, Ueno NT, Hawkins SM, Anderson ML, Matzuk
MM.
Mol Endocrinol. 2010 Feb;24(2):447-63.
The nuclear envelope can control gene expression and cell cycle progression via miRNA regulation.
Malhas A, Saunders NJ, Vaux DJ.
Cell Cycle. 2010 Feb;9(3):531-9.
Downregulation of miR-21 enhances chemotherapeutic effect of taxol in breast carcinoma cells.
Mei M, Ren Y, Zhou X, Yuan XB, Han L, Wang GX, Jia Z, Pu PY, Kang CS, Yao Z.
Technol Cancer Res Treat. 2010 Feb;9(1):77-86.
Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
Belian E, Kurucz R, Treue D, Lage H.
Anticancer Res. 2010 Feb;30(2):629-33.
Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer.
Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, Alattar M, Deepak J, Stass SA, Jiang F.
Lung Cancer. 2010 Feb;67(2):170-6.
Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status.
Zhou X, Ren Y, Moore L, Mei M, You Y, Xu P, Wang B, Wang G, Jia Z, Pu P, Zhang W, Kang C.
Lab Invest. 2010 Feb;90(2):144-55.
Down-regulation of dicer expression in ovarian cancer tissues.
Pampalakis G, Diamandis EP, Katsaros D, Sotiropoulou G.
Clin Biochem. 2010 Feb;43(3):324-7.
Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
Faggad A, Budczies J, Tchernitsa O, Darb-Esfahani S, Sehouli J, Müller BM, Wirtz R, Chekerov R, Weichert W, Sinn B, Mucha C, Elwali
NE, Schäfer R, Dietel M, Denkert C.
J Pathol. 2010 Feb;220(3):382-91.
Induction of microRNAs, mir-155, mir-222, mir-424 and mir-503, promotes monocytic differentiation through combinatorial regulation.
Forrest AR, Kanamori-Katayama M, Tomaru Y, Lassmann T, Ninomiya N, Takahashi Y, de Hoon MJ, Kubosaki A, Kaiho A, Suzuki M,
Yasuda J, Kawai J, Hayashizaki Y, Hume DA, Suzuki H.
Leukemia. 2010 Feb;24(2):460-6.
Cellular context-dependent "colors" of transforming growth factor-beta signaling.
Ikushima H, Miyazono K.
Cancer Sci. 2010 Feb;101(2):306-12.
Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent
indole-3-carbinol.
Melkamu T, Zhang X, Tan J, Zeng Y, Kassie F.
Carcinogenesis. 2010 Feb;31(2):252-8.
Genetic variation in MicroRNA genes and risk of oral premalignant lesions.
Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, Wu X.
Mol Carcinog. 2010 Feb;49(2):183-9.
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.
Chow TF, Mankaruos M, Scorilas A, Youssef Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, Pace KT, Yousef GM.
J Urol. 2010 Feb;183(2):743-51.
Overexpressed miR-494 down-regulates PTEN gene expression in cells transformed by
anti-benzo(a)pyrene-trans-7,8-dihydrodiol-9,10-epoxide.
Liu L, Jiang Y, Zhang H, Greenlee AR, Han Z.
Life Sci. 2010 Jan 30;86(5-6):192-8.
Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma.
Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H.
Mol Cancer. 2010 Jan 26;9:16.
ATM is down-regulated by N-Myc-regulated microRNA-421.
Hu H, Du L, Nagabayashi G, Seeger RC, Gatti RA.
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1506-11.
MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
Lovén J, Zinin N, Wahlström T, Müller I, Brodin P, Fredlund E, Ribacke U, Pivarcsi A, Påhlman S, Henriksson M.
Proc Natl Acad Sci U S A. 2010 Jan 26;107(4):1553-8.
MicroRNA-145 targets YES and STAT1 in colon cancer cells.
Gregersen LH, Jacobsen AB, Frankel LB, Wen J, Krogh A, Lund AH.
PLoS One. 2010 Jan 21;5(1):e8836.
miR-21: an oncomir on strike in prostate cancer.
Folini M, Gandellini P, Longoni N, Profumo V, Callari M, Pennati M, Colecchia M, Supino R, Veneroni S, Salvioni R, Valdagni R, Daidone
MG, Zaffaroni N.
Mol Cancer. 2010 Jan 21;9:12.
Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours.
Sheu SY, Grabellus F, Schwertheim S, Worm K, Broecker-Preuss M, Schmid KW.
Br J Cancer. 2010 Jan 19;102(2):376-82.
The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.
Klein U, Lia M, Crespo M, Siegel R, Shen Q, Mo T, Ambesi-Impiombato A, Califano A, Migliazza A, Bhagat G, Dalla-Favera R.
Cancer Cell. 2010 Jan 19;17(1):28-40.
All you need is a Mir-acle: the role of nontranslated RNAs in the suppression of B cell chronic lymphocytic leukemia.
Lichter P.
Cancer Cell. 2010 Jan 19;17(1):3-4.
SFSSClass: an integrated approach for miRNA based tumor classification.
Mitra R, Bandyopadhyay S, Maulik U, Zhang MQ.
BMC Bioinformatics. 2010 Jan 18;11 Suppl 1:S22.
MicroRNA expression differentiates histology and predicts survival of lung cancer.
Landi MT, Zhao Y, Rotunno M, Koshiol J, Liu H, Bergen AW, Rubagotti M, Goldstein AM, Linnoila I, Marincola FM, Tucker MA, Bertazzi PA,
Pesatori AC, Caporaso NE, McShane LM, Wang E.
Clin Cancer Res. 2010 Jan 15;16(2):430-41.
Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA, Benjamin H, Cholakh H, Chajut A, Clark DP, Westra WH.
Clin Cancer Res. 2010 Jan 15;16(2):610-9.
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological
features.
Bomben R, Dal-Bo M, Benedetti D, Capello D, Forconi F, Marconi D, Bertoni F, Maffei R, Laurenti L, Rossi D, Del Principe MI, Luciano F,
Sozzi E, Cattarossi I, Zucchetto A, Rossi FM, Bulian P, Zucca E, Nicoloso MS, Degan M, Marasca R, Efremov DG, Del Poeta G, Gaidano
G, Gattei V.
Clin Cancer Res. 2010 Jan 15;16(2):620-8.
MIRAGAA--a methodology for finding coordinated effects of microRNA expression changes and genome aberrations in cancer.
Gaire RK, Bailey J, Bearfoot J, Campbell IG, Stuckey PJ, Haviv I.
Bioinformatics. 2010 Jan 15;26(2):161-7.
miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7.
Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L.
Biochem Biophys Res Commun. 2010 Jan 15;391(3):1483-9.
Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas.
Klemke M, Meyer A, Hashemi Nezhad M, Belge G, Bartnitzke S, Bullerdiek J.
Cancer Genet Cytogenet. 2010 Jan 15;196(2):119-23.
A comprehensive catalogue of somatic mutations from a human cancer genome.
Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, Varela I, Lin ML, Ordóñez GR, Bignell GR, Ye K,
Alipaz J, Bauer MJ, Beare D, Butler A, Carter RJ, Chen L, Cox AJ, Edkins S, Kokko-Gonzales PI, Gormley NA, Grocock RJ, Haudenschild
CD, Hims MM, James T, Jia M, Kingsbury Z, Leroy C, Marshall J, Menzies A, Mudie LJ, Ning Z, Royce T, Schulz-Trieglaff OB, Spiridou A,
Stebbings LA, Szajkowski L, Teague J, Williamson D, Chin L, Ross MT, Campbell PJ, Bentley DR, Futreal PA, Stratton MR.
Nature. 2010 Jan 14;463(7278):191-6.
Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells.
Vrba L, Jensen TJ, Garbe JC, Heimark RL, Cress AE, Dickinson S, Stampfer MR, Futscher BW.
PLoS One. 2010 Jan 13;5(1):e8697.
[Effect of anti-cancer drugs on the expression of BIC/miR-155 in human pancreatic cancer PANC-1 cells]
Xia QS, Ishigaki Y, Sun L, Chen R, Motoo Y.
Zhonghua Yi Xue Za Zhi. 2010 Jan 12;90(2):123-7.
miR-221 overexpression contributes to liver tumorigenesis.
Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, Terris B, Mazzaferro V, Lowe SW, Croce CM, Dejean A.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):264-9.
Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer.
Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H.
Cancer. 2010 Jan 1;116(1):41-9.
miR-200a-mediated downregulation of ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma cell growth, migration and
invasion.
Xia H, Ng SS, Jiang S, Cheung WK, Sze J, Bian XW, Kung HF, Lin MC.
Biochem Biophys Res Commun. 2010 Jan 1;391(1):535-41.
MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1.
Sachdeva M, Mo YY.
Cancer Res. 2010 Jan 1;70(1):378-87.
Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical
resection.
Patnaik SK, Kannisto E, Knudsen S, Yendamuri S.
Cancer Res. 2010 Jan 1;70(1):36-45.
Definition of microRNAs that repress expression of the tumor suppressor gene FOXO1 in endometrial cancer.
Myatt SS, Wang J, Monteiro LJ, Christian M, Ho KK, Fusi L, Dina RE, Brosens JJ, Ghaem-Maghami S, Lam EW.
Cancer Res. 2010 Jan 1;70(1):367-77.
Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.
Oh JS, Kim JJ, Byun JY, Kim IA.
Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):5-8.
The Tasmanian devil transcriptome reveals Schwann cell origins of a clonally transmissible cancer.
Murchison EP, Tovar C, Hsu A, Bender HS, Kheradpour P, Rebbeck CA, Obendorf D, Conlan C, Bahlo M, Blizzard CA, Pyecroft S, Kreiss
A, Kellis M, Stark A, Harkins TT, Marshall Graves JA, Woods GM, Hannon GJ, Papenfuss AT.
Science. 2010 Jan 1;327(5961):84-7.
Tumorigenicity of the miR-17-92 cluster distilled.
van Haaften G, Agami R.
Genes Dev. 2010 Jan 1;24(1):1-4.
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival.
Greither T, Grochola LF, Udelnow A, Lautenschläger C, Würl P, Taubert H.
Int J Cancer. 2010 Jan 1;126(1):73-80.
EP300--a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas.
Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J.
Int J Cancer. 2010 Jan 1;126(1):114-24.
Role of microRNA in anticancer drug resistance.
Zheng T, Wang J, Chen X, Liu L.
Int J Cancer. 2010 Jan 1;126(1):2-10.
A microRNA expression ratio defining the invasive phenotype in bladder tumors.
Neely LA, Rieger-Christ KM, Neto BS, Eroshkin A, Garver J, Patel S, Phung NA, McLaughlin S, Libertino JA, Whitney D, Summerhayes IC.
Urol Oncol. 2010 Jan-Feb;28(1):39-48.
MicroRNAs and cancer: current state and future perspectives in urologic oncology.
Schaefer A, Jung M, Kristiansen G, Lein M, Schrader M, Miller K, Stephan C, Jung K.
Urol Oncol. 2010 Jan-Feb;28(1):4-13.
[RNA interference: biogenesis molecular mechanisms and its applications in cervical cancer]
Peralta-Zaragoza O, Bermúdez-Morales VH, Madrid-Marina V.
Rev Invest Clin. 2010 Jan-Feb;62(1):63-80.
MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, Zhen JJ, Chen C, Zhang ZM, Xu W, Luo XZ, Wang D.
J Gastroenterol Hepatol. 2010 Jan;25(1):164-71.
MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
Hummel R, Hussey DJ, Haier J.
Eur J Cancer. 2010 Jan;46(2):298-311.
[Novel mechanisms of drug resistance in cancer]
Ochiya T.
Seikagaku. 2010 Jan;82(1):34-8.
Gene silencing of MIR22 in acute lymphoblastic leukaemia involves histone modifications independent of promoter DNA methylation.
Li X, Liu J, Zhou R, Huang S, Huang S, Chen XM.
Br J Haematol. 2010 Jan;148(1):69-79.
Differential expression profiling of microRNAs and their potential involvement in renal cell carcinoma pathogenesis.
Chow TF, Youssef YM, Lianidou E, Romaschin AD, Honey RJ, Stewart R, Pace KT, Yousef GM.
Clin Biochem. 2010 Jan;43(1-2):150-8.
Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous
adenocarcinomas.
Hiroki E, Akahira J, Suzuki F, Nagase S, Ito K, Suzuki T, Sasano H, Yaegashi N.
Cancer Sci. 2010 Jan;101(1):241-9.
MicroRNAs: Oncogenes, tumor suppressors or master regulators of cancer heterogeneity?
Voorhoeve PM.
Biochim Biophys Acta. 2010 Jan;1805(1):72-86.
MicroRNAs in the tumor endothelium: novel controls on the angioregulatory switchboard.
Heusschen R, van Gink M, Griffioen AW, Thijssen VL.
Biochim Biophys Acta. 2010 Jan;1805(1):87-96.
High expression of microRNA-15b predicts a low risk of tumor recurrence following curative resection of hepatocellular carcinoma.
Chung GE, Yoon JH, Myung SJ, Lee JH, Lee SH, Lee SM, Kim SJ, Hwang SY, Lee HS, Kim CY.
Oncol Rep. 2010 Jan;23(1):113-9.
5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.
Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W, Bai C.
Oncol Rep. 2010 Jan;23(1):121-8.
RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer.
Yang G, Fu H, Zhang J, Lu X, Yu F, Jin L, Bai L, Huang B, Shen L, Feng Y, Yao L, Lu Z.
Gastroenterology. 2010 Jan;138(1):231-40.e1-5.
Localization- and mutation-dependent microRNA (miRNA) expression signatures in gastrointestinal stromal tumours (GISTs), with a cluster
of co-expressed miRNAs located at 14q32.31.
Haller F, von Heydebreck A, Zhang JD, Gunawan B, Langer C, Ramadori G, Wiemann S, Sahin O.
J Pathol. 2010 Jan;220(1):71-86.
Integrated genomics of chemotherapy resistant ovarian cancer: a role for extracellular matrix, TGFbeta and regulating microRNAs.
Helleman J, Jansen MP, Burger C, van der Burg ME, Berns EM.
Int J Biochem Cell Biol. 2010 Jan;42(1):25-30.
Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath
tumours.
Subramanian S, Thayanithy V, West RB, Lee CH, Beck AH, Zhu S, Downs-Kelly E, Montgomery K, Goldblum JR, Hogendoorn PC, Corless
CL, Oliveira AM, Dry SM, Nielsen TO, Rubin BP, Fletcher JA, Fletcher CD, van de Rijn M.
J Pathol. 2010 Jan;220(1):58-70.
MicroRNAs and cancer epigenetics: a macrorevolution.
Davalos V, Esteller M.
Curr Opin Oncol. 2010 Jan;22(1):35-45.
The many roles of microRNAs in brain tumor biology.
Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, Kalani MY.
Neurosurg Focus. 2010 Jan;28(1):E3.
Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years.
Northcott PA, Rutka JT, Taylor MD.
Neurosurg Focus. 2010 Jan;28(1):E6.
Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs.
Izzotti A, Calin GA, Steele VE, Cartiglia C, Longobardi M, Croce CM, De Flora S.
Cancer Prev Res (Phila Pa). 2010 Jan;3(1):62-72.
Hsa-mir-125b-2 is highly expressed in childhood ETV6/RUNX1 (TEL/AML1) leukemias and confers survival advantage to growth inhibitory
signals independent of p53.
Gefen N, Binder V, Zaliova M, Linka Y, Morrow M, Novosel A, Edry L, Hertzberg L, Shomron N, Williams O, Trka J, Borkhardt A, Izraeli S.
Leukemia. 2010 Jan;24(1):89-96.
HLungDB: an integrated database of human lung cancer research.
Wang L, Xiong Y, Sun Y, Fang Z, Li L, Ji H, Shi T.
Nucleic Acids Res. 2010 Jan;38(Database issue):D665-9.
Epigenetics in cancer.
Sharma S, Kelly TK, Jones PA.
Carcinogenesis. 2010 Jan;31(1):27-36.
Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype.
Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, Buckstein R, Lam
W, Humphries RK, Karsan A.
Nat Med. 2010 Jan;16(1):49-58.
Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.
Schetter AJ, Heegaard NH, Harris CC.
Carcinogenesis. 2010 Jan;31(1):37-49.
Leukaemogenesis: more than mutant genes.
Chen J, Odenike O, Rowley JD.
Nat Rev Cancer. 2010 Jan;10(1):23-36.
Cancer: Small losses, big gains with microRNAs.
McCarthy N.
Nat Rev Genet. 2010 Jan;11(1):8.
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial
transition.
Bendoraite A, Knouf EC, Garg KS, Parkin RK, Kroh EM, O'Briant KC, Ventura AP, Godwin AK, Karlan BY, Drescher CW, Urban N,
Knudsen BS, Tewari M.
Gynecol Oncol. 2010 Jan;116(1):117-25.
MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.
Slaby O, Lakomy R, Fadrus P, Hrstka R, Kren L, Lzicarova E, Smrcka M, Svoboda M, Dolezalova H, Novakova J, Valik D, Vyzula R,
Michalek J.
Neoplasma. 2010;57(3):264-9.
MicroRNA profiles of drug-resistant myeloma cell lines.
Munker R, Liu CG, Taccioli C, Alder H, Heerema N.
Acta Haematol. 2010;123(4):201-4.
Regulation of p27(kip1) mRNA expression by microRNAs.
Martínez-Sánchez A, Gebauer F.
Prog Mol Subcell Biol. 2010;50:59-70.
miRNA expression in a human papillary thyroid carcinoma cell line varies with invasiveness.
Gao Y, Wang C, Shan Z, Guan H, Mao J, Fan C, Wang H, Zhang H, Teng W.
Endocr J. 2010;57(1):81-6.
Increased expression of miR-421 in human gastric carcinoma and its clinical association.
Jiang Z, Guo J, Xiao B, Miao Y, Huang R, Li D, Zhang Y.
J Gastroenterol. 2010;45(1):17-23.